Pharma-Bio Serv (OTCMKTS:PBSV) Announces Earnings Results

Pharma-Bio Serv (OTCMKTS:PBSV) issued its earnings results on Monday. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.02 by $0.35, reports. Pharma-Bio Serv had a negative net margin of 8.18% and a negative return on equity of 5.61%. The company had revenue of $2.47 million during the quarter, compared to analyst estimates of $2.70 million.

Pharma-Bio Serv Stock Performance

Shares of Pharma-Bio Serv stock opened at $0.43 on Wednesday. The firm’s 50-day simple moving average is $0.55 and its 200-day simple moving average is $0.57. Pharma-Bio Serv has a twelve month low of $0.31 and a twelve month high of $0.90. The firm has a market cap of $9.86 million, a P/E ratio of -14.33 and a beta of 0.53.

Pharma-Bio Serv Dividend Announcement

The business also recently announced a dividend, which will be paid on Thursday, March 20th. Investors of record on Friday, February 28th will be paid a $0.075 dividend. The ex-dividend date of this dividend is Friday, February 28th. Pharma-Bio Serv’s payout ratio is presently -250.00%.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.